Skip to content
biospace.com· Gabrielle Masson·· 4 hours agoPickScore56

Biotech notches 31 IPOs already this year, with 4 more joining queue

In brief

Thirty-one biotech companies have completed IPOs so far in 2026, with four more having filed to go public. BioSpace data show this total far exceeds 2025's eight IPOs and also tops 2024 (19), 2023 (13) and 2022 (17), though it remains far below the nearly 100 in 2021.

Why it matters

Placing this year's 31 IPOs alongside 2025's 8, 2024's 19 and 2021's nearly 100, with quarterly distribution and largest raise, lets readers judge where the rebound stands.

Source: biospace.com · biospace.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org